Long-term survival of adrenal metastasis from non-small cell lung cancer
Tóm tắt
Long-term survival of patients who undergo surgical resection of isolated adrenal metastasis from non-small cell lung cancer (NSCLC) has been reported. In these patients, primary lung cancers were generally resected or resectable. We report a 50-year-old man of NSCLC (T3N2M1) with locally advanced lung adenocarcinoma and solitary ipsilateral adrenal metastasis, which was detected by FDG/PET (fluorodeoxyglucose/positron emission tomography). After the thoracic lesions had been controlled with chemo-radiation therapy for 2 years, the remaining adrenal metastasis was surgically resected. He was disease-free for 7 years. Our case suggests that solitary adrenal metastasis may be resectable in NSCLC patients controlled by chemo-radiation therapy, and FDG/PET is useful to detect and follow adrenal metastasis.
Tài liệu tham khảo
Pfannschmidt J, Dienemann H (2010) Surgical treatment of oligometastatic non-small cell lung cancer. Lung cancer 69:251–258
Porte HL, Roumilhac D, Graziana JP et al (1998) Adrenalectomy for a solitary adrenal metastasis from lung cancer. Ann Thorac Surg 65:331–335
Porte H, Siat J, Guibert B et al (2001) Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 71:981–985
Raz DJ, Lanuti M, Gaissert HC et al (2011) Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma. Ann Thorac Surg 92:1788–1793
NCCN (2012) NCCN Guidelines: non-small cell lung cancer version 2.2012. Available via NCCN. www.nccn.com. Accessed 26 Feb 2012
Tanvetyanon T, Robinson LA, Schell MJ et al (2008) Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systemic review and pooled analysis. J Clin Oncol 26:1142–1147
Karolyi P (1990) Do adrenal metastases from lung cancer developed by lymphogenous of hematogenous route? J Surg Oncol 43:154–156
Kumar R, Xiu Y, Yu JQ et al (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45:2058–2062
Yamamoto N, Nakagawa K, Nishimura Y et al (2010) Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patient with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG 0105. J Clin Oncol 28:3739–3745